Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$72.61 - $90.2 $267,713 - $332,567
-3,687 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$71.87 - $131.03 $8,768 - $15,985
-122 Reduced 3.2%
3,687 $280,000
Q2 2020

Aug 10, 2020

BUY
$79.55 - $124.22 $303,005 - $473,153
3,809 New
3,809 $463,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Opseu Pension Plan Trust Fund Portfolio

Follow Opseu Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opseu Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Opseu Pension Plan Trust Fund with notifications on news.